DDS vs KSS: Which Is the Better Buy in 2026?

Last updated November 2026

Short answer

DDS is the larger of the two ($10.12B market cap): the incumbent the market prices for continued execution (18.77x forward earnings, beta 1.07). KSS is the smaller challenger ($2.74B), cheaper on forward earnings (15.45x): more room to run, but more to prove. The real question is which set of drivers you believe, and whether owning one (or both) leaves you over-concentrated.

DDS vs KSS: the tie-breaker metrics

Same yardstick, side by side (as of November 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

MetricDDSKSSWhat it tells you
Market cap$10.12B$2.74BSize. The larger name is the incumbent; the smaller has more room to grow and more to prove.
Forward P/E18.7715.45Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up.
Trailing P/E14.8410.36Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price.
Beta1.071.33Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through.
Price vs 52-week range61% of range92% of rangeWhere today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why.
Price / book4.770.65How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price.

Reading it: KSS is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

Before you buy: how DDS and KSS affect your concentration

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. DDS and KSS share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined DDS and KSS exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

What does Dillard's (DDS) do?

Dillard's sells apparel, cosmetics, footwear and home goods through about 272 stores (roughly 28 of them clearance centers) in about 30 states, concentrated in Texas, Florida and the rest of the Sun Belt, plus dillards.com. Total selling space is around ~46 million square feet, and unlike most mall-anchor peers Dillard's owns the large majority of that space outright rather than leasing it. A second, unglamorous segment is CDI Contractors, a general contracting business that builds and remodels Dillard's own stores and takes third-party commercial work. Fiscal 2025, the 52 weeks ended January 31, 2026, produced net sales of about ~$6.47 billion and net income of about ~$570 million, or roughly ~$36.42 per share.

Full DDS guide

What does Kohl's (KSS) do?

Kohl's Corporation operates a chain of roughly 1,150 department stores across most of the United States, most of them in suburban strip centers rather than enclosed malls. It sells moderately priced apparel, footwear, accessories, home goods, and beauty products, mixing national brands with a meaningful slate of proprietary and exclusive labels that carry higher margins. The company makes money on retail merchandise sales both in store and online (digital reached about 26% of net sales in early 2026), and it also earns fee income from its co-branded Kohl's Card credit program. Loyalty mechanics like Kohl's Cash and Kohl's Rewards are central to how it drives repeat traffic.

Full KSS guide

DDS vs KSS: how do they differ?

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

  • DDS drivers: The shrinking share count; Merchandise margin and inventory discipline.
  • KSS drivers: Sephora beauty as a traffic engine; Owned real estate and asset value.

Which fits which kind of investor

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. A useful test is which set of risks you could hold through a drawdown: Department stores are in secular decline, and Dillard's is not adding stores, so any growth has to come from comparable sales and margin rather than square footage. For KSS, the core bear case is secular: department stores have been losing share for years to off-price chains, mass merchants, and online retail, and Kohl's revenue keeps edging down (about -0.9% year over year in the latest quarter) even as declines narrowed.

DDS or KSS: which should you pick?

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick DDS if you believe its drivers more; KSS if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the DDS and KSS guides.

DDS vs KSS: the full fundamentals

DDS. The trailing multiple near ~15x is normal for a department store, but trailing earnings include the interchange settlement gain, so the forward multiple sits closer to ~19.5x on analysts' estimate of ~$34.50 for the fiscal year ending January 2028. The shares trade above the ~$546 average target after a ~22% three-month rally. The next report, covering the quarter ending around October 31, is expected around November 12, 2026, with consensus EPS near ~$8.05.

KSS. These figures are approximate and tied to the asOf date; verify current numbers before acting. The central valuation debate is still whether Kohl's is cheap for a reason, but the rally after the Q2 beat has pushed the price above the average analyst target, and the forward multiple near 14x reflects expectations that earnings fall next year. With thin operating margins and still-shrinking sales, small swings in either direction move the equity and the dividend's coverage significantly.

Headline figures (approximate, October 2026): DDS shows revenue (ttm) ~$6.6B, roughly flat (Q2 FY2026 ~-0.4% yoy), q2 fy2026 (quarter ended aug 1, 2026) Sales ~$1.53B; EPS ~$6.26 vs ~$4.21 expected, net income (ttm) ~$682M, diluted eps (ttm) ~$43.64; KSS shows revenue (ttm, approx.) ~$15.4 billion (latest quarter ~-1% YoY), net income (ttm) ~$270 million (~1.8% net margin), q2 fy2026 eps $1.28 vs ~$0.57 estimate, p/e ratio (trailing / forward) ~9.5x / ~14x.

The bottom line: DDS vs KSS

DDS and KSS are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined DDS and KSS exposure against your real portfolio. It is not an investment adviser.

Wondering how DDS or KSS fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.

Investing in Dillard's with AI

Connect the broker you already use and ask Walnut's AI how DDS fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.

FAQ

What is the difference between DDS and KSS?

+

Dillard's sells apparel, cosmetics, footwear and home goods through about 272 stores (roughly 28 of them clearance centers) in about 30 states, concentrated in Texas, Florida and the rest of the Sun Belt, plus dillards.com. Kohl's Corporation operates a chain of roughly 1,150 department stores across most of the United States, most of them in suburban strip centers rather than enclosed malls. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.

Is DDS or KSS the better stock?

+

Neither is universally better. DDS is the larger incumbent; KSS is the smaller challenger and looks cheaper on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.

Which is cheaper, DDS or KSS?

+

On forward P/E (as of November 2026), DDS trades at 18.77x and KSS at 15.45x, so KSS is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.

Should you own both DDS and KSS?

+

Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.

What are the risks of DDS vs KSS?

+

DDS: Department stores are in secular decline, and Dillard's is not adding stores, so any growth has to come from comparable sales and margin rather than square footage. Sun Belt concentration ties results tightly to Texas and Florida consumer spending and to mall traffic in those markets. Q1 fiscal 2026 earnings were flattered by the ~$104.1 million pre-tax interchange settlement gain, which will not repeat, so year-over-year comparisons in fiscal 2027 face a hole. Apparel tariffs and import costs pressure the merchandise margin that carries the whole model. Governance and liquidity are both concentrated: the Dillard family elects the board majority through Class B stock, only about 3 analysts publish estimates with an average target near ~$546 (below the ~$671 share price) and an underperform consensus, and the small float has historically drawn heavy short interest that amplifies moves in both directions. Analysts expect EPS to slip to about ~$34.50 in the fiscal year ending January 2028, which is why the forward P/E (~19.5x) sits above the trailing one. The October 2026 move of the primary listing to the new Texas Stock Exchange is untested territory for trading liquidity, though the ticker is unchanged. KSS: The core bear case is secular: department stores have been losing share for years to off-price chains, mass merchants, and online retail, and Kohl's revenue keeps edging down (about -0.9% year over year in the latest quarter) even as declines narrowed. Margins are thin (trailing operating margin about 4.6% and net margin under 2%), leaving little cushion, and recent reports that Kohl's has been cutting prices on key items as customer interest fades raise questions about how durable the margin gains are. After the rally, the stock trades above the average analyst target (about $18.88, with a hold consensus), and analysts expect third-quarter EPS near zero. The balance sheet carries about $6.4 billion of debt, including leases, against $821 million of cash. The dividend was already reduced and could be trimmed again if earnings weaken. Execution risk is elevated after heavy leadership turnover, including a CEO terminated for cause in 2025 after only months on the job before a permanent CEO was named in late 2025.

Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell DDS or KSS; figures are approximate and dated (as of November 2026). Verify current data before investing.